Table 1. An accelerated stability study of SFT in the gel formulation.

Intervals	% Inhibition of HIV-1 infectiona
	SFT in gel				SFT in PBS
	4°C	RTb	30°C	40°C	4°C	RT	30°C	40°C
Week 0	91.34±0.84	89.71±2.03	91.63±0.38	94.16±1.89	89.09±1.97	88.21±2.71	89.15±2.76	88.84±2.11
Week 1	80.54±1.04	96.84±1.15	92.09±1.70	94.91±2.88	94.69±1.64	92.08±1.23	92.62±2.31	94.48±1.41
Week 2	87.05±0.87	93.95±3.45	94.26±2.63	88.23±3.27	85.21±0.94	89.56±3.86	92.20±2.57	86.36±0.98
Week 3	89.76±0.16	87.28±1.88	89.51±0.49	88.77±2.35	88.71±3.41	84.64±1.47	90.68±0.11	81.73±4.66
Week 4	93.33±0.95	96.25±2.04	99.10±0.35	99.27±0.26	84.77±0.87	81.82±3.37	98.82±0.95	87.92±3.74
Week 5	93.80±1.63	95.03±1.69	93.92±1.10	87.92±2.72	92.61±2.88	93.79±2.43	90.54±0.68	92.67±1.24
Week 6	90.99±0.44	93.47±1.73	92.81±1.65	87.88±0.57	90.61±1.36	88.01±3.06	90.20±2.16	88.89±4.43
Week 7	93.22±4.43	90.64±1.70	89.66±4.01	92.32±1.02	93.16±1.44	92.06±1.01	93.67±0.82	92.80±1.80
Week 8	93.02±0.77	91.31±3.30	90.88±4.58	82.70±2.36	91.30±1.54	90.89±1.67	87.76±4.09	91.33±2.25

^aData represent mean ± SD (n = 3).

^bRT: room temperature.